Ionis Pharmaceuticals, Inc. is a leading biotechnology company developing RNA-targeted therapeutics. The company's innovative drug discovery platform has created a large pipeline of first-in-class or best-in-class drugs, with over 40 drugs in development. Ionis' drugs are designed to treat a wide range of diseases, including cardiovascular, metabolic, neurological, and rare diseases. The company's mission is to improve the lives of patients by creating innovative medicines that target the underlying cause of disease. Ionis has a strong track record of success, with multiple drugs approved by the FDA and partnerships with leading pharmaceutical companies.